Sort
48,018 grants matching “immunotherapy”
Role of exosomal SPHK1 in ovarian cancer progression
$377,679Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2022 · CA
Role of Tim-3 in determining T cell immunity
$377,666Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2016 · CA
Role of Tim-3 in determining T cell immunity
$377,666Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2017 · CA
Role of Tim-3 in determining T cell immunity
$377,666Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2018 · CA
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
$377,656Matthias Gromeier · Duke University · R01 · FY2023 · CA
Quality and location of presented Ag as determinants of tumor-specific immunity
$377,646Victor H. Engelhard · University Of Virginia · R01 · FY2009 · CA
Project 5
$377,638Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Regulation of gamma delta T cell immunoediting by novel phosphoantigens
$377,585Andrew J Wiemer · University Of Connecticut Storrs · R01 · FY2016 · CA
Evaluation of image-guided, conformal, high-dose intraoperative radiation therapy (Precision Breast IORT) for early stage breast cancer
$377,571Shayna Lefrak Showalter · University Of Virginia · R01 · FY2022 · CA
Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain
$377,544Jeffrey Victor Ravetch · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Comparative MHC and KIR immunogenetics in the Great Apes
$377,544Peter R Parham · Stanford University · R01 · FY2016 · AI
Development of a multi-antigen, multi-peptide vaccine HHSN2612015000371 TORFP 2017-E09 PP: 9/15/17 to 11/14/18
$377,537Yiang Wang · Medical College Of Wisconsin · N01 · FY2017 · CA
NKT cell subsets modulate systemic inflammation
$377,500Charles Thomas Spencer · University Of Texas El Paso · SC1 · FY2022 · AI
NKT cell subsets modulate systemic inflammation
$377,500Charles Thomas Spencer · University Of Texas El Paso · SC1 · FY2021 · AI
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease
$377,500Janardan P Pandey · Medical University Of South Carolina · R01 · FY2023 · AG
New Treatments for Chronic Chagas Disease
$377,500Rosa A Maldonado · University Of Texas El Paso · SC1 · FY2022 · GM
NKT cell subsets modulate systemic inflammation
$377,500Charles Thomas Spencer · University Of Texas El Paso · SC1 · FY2020 · AI
New Treatments for Chronic Chagas Disease
$377,500Rosa A Maldonado · University Of Texas El Paso · SC1 · FY2024 · GM
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease
$377,500Janardan P Pandey · Medical University Of South Carolina · R01 · FY2024 · AG
Development of tolerogenic dendritic cell-based immunotherapies and restorative insulin approaches to alleviate type 1 diabetes
$377,500Michael W Lipscomb · Howard University · SC1 · FY2019 · GM
Development of tolerogenic dendritic cell-based immunotherapies and restorative insulin approaches to alleviate type 1 diabetes
$377,500Michael W Lipscomb · Howard University · SC1 · FY2021 · GM
NKT cell subsets modulate systemic inflammation
$377,500Charles Thomas Spencer · University Of Texas El Paso · SC1 · FY2019 · AI
Development of tolerogenic dendritic cell-based immunotherapies and restorative insulin approaches to alleviate type 1 diabetes
$377,500Michael W Lipscomb · Howard University · SC1 · FY2020 · GM
New Treatments for Chronic Chagas Disease
$377,500Rosa A Maldonado · University Of Texas El Paso · SC1 · FY2023 · GM
HAT Inhibition to Impair Foxp3+ Treg Function and Boost Anti-Tumor Immunity
$377,474Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2011 · CA